Sanofi Faces China Bribery Probe Over Whistleblower Claims

Law360, New York (August 12, 2013, 2:31 PM EDT) -- Sanofi SA on Monday confirmed that it had been accused by a whistleblower of paying kickbacks to Chinese doctors for prescriptions under the guise of “research grants,” following reports that Chinese officials have launched a probe into the allegations.

The French pharmaceutical giant said in a statement Monday that it was aware of the allegations that it had paid out about 1.7 million yuan ($276,000) in bribes to more than 500 Chinese doctors in late 2007 under the guise of “research grants,” published last week in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.